Subcutanous Ocrevus Zunovo as a New Treatment Option for Multiple Sclerosis

In this episode, Scott D. Newsome, DO, Professor of Neurology, Johns Hopkins University, Baltimore, MD, discusses how Ocrevus Zunovo can be used to treat primary progressive and relapsing forms of multiple sclerosis, including how the drug is administered, research related to the efficacy of this formulation, and the impact on clinical practice and patients.